Remain Vigilant: Highly Pathogenic Avian Influenza | 05.01.24 Update

Remain Vigilant: Highly Pathogenic Avian Influenza | 05.01.24 Update
05.01.2024

As the influenza season has ended, providers are asked to consider the possibility of Highly Pathogenic Avian Influenza (HPAI) in persons showing flu-like symptoms or conjunctivitis who have relevant exposure history.

Risk of HPAI Exposure
  • HPAI is a virus found among birds, including wild migratory waterfowl and domestic poultry.
  • As avian influenza is now endemic to our native waterfowl, it is anticipated to see more cases regionally in domesticated birds and cattle with the spring return of migratory waterfowl.
  • Although rare, most previous HPAI infections of people have occurred following close, prolonged, and unprotected contact with infected poultry or their environments.
  • Human-to-human transmission of HPAI has not yet been documented.
HPAI Provider Guidance
  • Ask patients with flu symptoms about recent travel, animal exposure, and raw milk consumption.
  • All exposed individuals to a known case of HPAI should be tested. Please work with your local health department who will coordinate patient testing and monitor those exposed.
  • Suspected HPAI cases should be treated with Tamiflu if symptomatic then follow respiratory/contact precautions.
  • MDHHS recommends promoting seasonal influenza vaccines to those at risk of exposure to HPAI to reduce the risk of viral mixing between seasonal and avian strains of influenza that can occur with co-infection.
  • According to the CDC, the public health risk associated with HPAI remains low.

For more information on Avian Influenza, and other trending medical topics, please visit Munson’s Library Services website.

Questions? Contact your local health department.